Skip to main content
Fig. 5 | Respiratory Research

Fig. 5

From: Navafenterol (AZD8871) in healthy volunteers: safety, tolerability and pharmacokinetics of multiple ascending doses of this novel inhaled, long-acting, dual-pharmacology bronchodilator, in two phase I, randomised, single-blind, placebo-controlled studies

Fig. 5

Geometric mean plasma concentration-time profiles of navafenterol (pharmacokinetic population) on days 1 and 16 in (a) study A and (b) study B, and pre-dose concentrations from days 6 to 16 in (c) study A and (d) study B. Note that a longer sampling scheme was used in study B (samples collected up to 336 h following the last dose) than in study A (samples collected up to 96 h following the last dose). SD = geometric standard deviation

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us